Discover 501 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 501
Active & ResponsiveNew
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: 1 recruiting location
Sponsor: Ipsen
Sex: All
Age: 18+
Code: NCT07213830
Phase1, Phase2, Recruiting
Active & Responsive
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
for
Suicidal Ideation, Major Depressive Disorder,
Location: 1 recruiting location
Sponsor: Michigan State University
Sex: All
Age: 18 - 70+
Code: NCT06529029
Phase2, Phase3, Recruiting
Active & Responsive
Fenofibrate for Prevention of DR Worsening
for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18 - 70+
Code: NCT04661358
Phase3, Recruiting
Active & Responsive
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
for
Advanced Solid Tumor
Location: 6 recruiting locations
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06750185
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
for
Triple Negative Breast Cancer (TNBC),
Location: 9 recruiting locations
Sponsor: Boundless Bio
Sex: All
Age: 18+
Code: NCT05827614
Phase1, Recruiting
Active & Responsive
Study of Oral MRT-2359 in Selected Cancer Patients
for
NSCLC, SCLC, High Grade Neuroendocrine Cancer, DLBCL,
Location: 15 recruiting locations
Sponsor: Monte Rosa Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT05546268
Phase1, Phase2, Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: 21 recruiting locations
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,